Detalhe da pesquisa
1.
P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma.
Mol Cell Proteomics
; 22(3): 100504, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708875
2.
Identification of MYCN non-amplified neuroblastoma subgroups points towards molecular signatures for precision prognosis and therapy stratification.
Br J Cancer
; 130(11): 1841-1854, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553589
3.
MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma.
BMC Cancer
; 21(1): 784, 2021 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233647
4.
Angiomatoid fibrous histiocytoma with Castleman disease: A case report.
Pediatr Blood Cancer
; 68(2): e28590, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32672859
5.
The potential mechanism of Aidi injection against neuroblastoma-an investigation based on network pharmacology analysis.
Front Pharmacol
; 15: 1310009, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38313313
6.
PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis.
Cell Death Dis
; 13(2): 178, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210406
7.
Pancancer analyses reveal the regulation and clinical outcome association of PCLAF in human tumors.
Int J Oncol
; 60(6)2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35425993